Reinfected patients had a more than doubled risk of death and a more than tripled risk of hospitalization.

The findings suggested that a component of this protein, called viral polymerase, could potentially be added to COVID-19 vaccines to create...

Among 70 cases reported in Europe that included information on disease severity, half of the patients had no symptoms and half had mild sym...

Sankar Ghosh is the Silverstein and Hutt Family Professor of Microbiology and chair of the Department of Microbiology & Immunology at the V...

“The committee is Delhi centric and dominated by disciplines not connected to vaccines and clinical research. Like in the US such important...

Work on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment F...

The Australian immunologist, who cautioned that the number of COVID-19 cases will rise in the coming days, said the earliest time frame for...

The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known to produce...

The meeting offers researchers an opportunity to closely interact with Nobel laureates from their discipline over seven days.

The bench said it will hear the matter, but Noothi's lawyer Rahul Totala moved a separate plea to tag his matter with another case pending ...

Dengue is a viral infection spread between humans by Aedes aegypti mosquitoes. Dengue causes flu-like symptoms, including intense headaches...

Bacteria that help us digest the yeast that give beer & bread their bubbles could support the development of new treatments to help people ...

The vaccination aims to reduce the number of chronic carriers who could infect others and themselves develop liver cancers or cirrhosis lat...

Researchers have found that the same protein possesses a unique ability to block the release of HIV-1 and Ebola virus.

Span Diagnostics today said it has received an order of Rs 21.45 crore from the government to supply human immunodeficiency virus rapid tes...

A four-day international symposium will be held here from tomorrow to discuss disease prevention and treatment through immunisation.